Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Chan

Showing results (131-140 of 195) with videos related to

Pageof 20
Sort By:
The Journal of Urology|October 9, 2003
Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trialAlan W Partin, Michael K Brawer, Georg Bartsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
HLA-G is a potential tumor marker in malignant ascitesGad Singer, Vera Rebmann, Yu-Chi Chen, et al.
Clinical Chemistry|July 9, 2008
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirementsCatharine M Sturgeon, Barry R Hoffman, Daniel W Chan, et al.
Proteomics|July 30, 2005
Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identification of biomarkersAlex J Rai, Paul M Stemmer, Zhen Zhang, et al.
Journal of Proteome Research|November 21, 2013
A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serumTujin Shi, Yuqian Gao, Sue Ing Quek, et al.
Clinical Chemistry and Laboratory Medicine|October 15, 2009
Development and analytical performance evaluation of an automated chemiluminescent immunoassay for pro-gastrin releasing peptide (ProGRP)Toru Yoshimura, Kenju Fujita, Hideki Kinukawa, et al.
The International Journal of Biological Markers|October 25, 2011
Improvement and multicenter evaluation of the analytical performance of an automated chemiluminescent immunoassay for alpha fetoproteinKaori Morota, Makoto Komori, Ryo Fujinami, et al.
BJU International|October 16, 2016
Prostate Health Index improves multivariable risk prediction of aggressive prostate cancerStacy Loeb, Sanghyuk S Shin, Dennis L Broyles, et al.
Urology|October 18, 2002
Complexed prostate-specific antigen as a staging tool: results based on a multicenter prospective evaluation of complexed prostate-specific antigen in cancer diagnosisSamir S Taneja, Elias I Hsu, Carol D Cheli, et al.
Gynecologic Oncology|October 9, 2007
Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancerZhen Zhang, Yinhua Yu, Fengji Xu, et al.
Pageof 20

Showing results (131-140 of 195) with videos related to

Sort By:
Pageof 20
The Journal of Urology|October 9, 2003
Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trialAlan W Partin, Michael K Brawer, Georg Bartsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
HLA-G is a potential tumor marker in malignant ascitesGad Singer, Vera Rebmann, Yu-Chi Chen, et al.
Clinical Chemistry|July 9, 2008
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirementsCatharine M Sturgeon, Barry R Hoffman, Daniel W Chan, et al.
Proteomics|July 30, 2005
Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identification of biomarkersAlex J Rai, Paul M Stemmer, Zhen Zhang, et al.
Journal of Proteome Research|November 21, 2013
A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serumTujin Shi, Yuqian Gao, Sue Ing Quek, et al.
Clinical Chemistry and Laboratory Medicine|October 15, 2009
Development and analytical performance evaluation of an automated chemiluminescent immunoassay for pro-gastrin releasing peptide (ProGRP)Toru Yoshimura, Kenju Fujita, Hideki Kinukawa, et al.
The International Journal of Biological Markers|October 25, 2011
Improvement and multicenter evaluation of the analytical performance of an automated chemiluminescent immunoassay for alpha fetoproteinKaori Morota, Makoto Komori, Ryo Fujinami, et al.
BJU International|October 16, 2016
Prostate Health Index improves multivariable risk prediction of aggressive prostate cancerStacy Loeb, Sanghyuk S Shin, Dennis L Broyles, et al.
Urology|October 18, 2002
Complexed prostate-specific antigen as a staging tool: results based on a multicenter prospective evaluation of complexed prostate-specific antigen in cancer diagnosisSamir S Taneja, Elias I Hsu, Carol D Cheli, et al.
Gynecologic Oncology|October 9, 2007
Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancerZhen Zhang, Yinhua Yu, Fengji Xu, et al.
Pageof 20